Health-economic Evaluation of Interventional Pain Management Compared to Pain Rehabilitation
1 other identifier
observational
15,611
1 country
2
Brief Summary
The overall aim of the study is to evaluate interventional pain management. This is done in three steps:
- 1.To find matched controls to the patients in the study on cost-effectiveness of IPM and compare the results.
- 2.To calculate cost-effectiveness of PRP during the period 2010-2016, on a national level.
- 3.To calculate cost-effectiveness of PRP during the period 2017-2019, after the changed guidelines for PRP in Sweden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2020
CompletedStudy Start
First participant enrolled
December 1, 2020
CompletedFirst Posted
Study publicly available on registry
December 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedFebruary 16, 2023
July 1, 2022
1.1 years
December 1, 2020
February 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Health-related quality of life
EQ-5D index
1 year
Study Arms (2)
2010-2016
Patients treated 2010-2016
2017-2019
Patients treated 2017-2019
Interventions
Effect on health related quality of life och health-care consumption after rehabilitation
Eligibility Criteria
Patients that have been treated with pain rehabilitation programs and that have been registered prospectively in the national register for pain rehabilitation in Sweden
You may qualify if:
- Been through pain rehabilitation program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eques Indolor ABlead
- Umeå Universitycollaborator
Study Sites (2)
Department of Epidemiology and Global Health Umeå University
Umeå, 90185, Sweden
Smärtkliniken Eques Indolor
Vallentuna, 18695, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lars Lindholm
PhD
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2020
First Posted
December 8, 2020
Study Start
December 1, 2020
Primary Completion
December 30, 2021
Study Completion
September 30, 2022
Last Updated
February 16, 2023
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share
Sharing IPD is restricted by law in Sweden and any sharing needs a specific approval from ethics board